FDA Approved: TYKERB — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for Tykerb (lapatinib) by Novartis Pharmaceuticals Corporation. The action updates the product labeling as part of the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tykerb (lapatinib)

Snippet

SUPPL AP for TYKERB (LAPATINIB)